# Federal Home Loan Mortgage Corp: financial statements, quarterly

FMCC · OTC · CIK 1026214 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmcc.md) · [Financials](/companies/fmcc/financials.md) · [Filings](/companies/fmcc/filings.md) · [Insiders](/companies/fmcc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fmcc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [5.7](/filings/0001026214-24-000097.md) | [5.4 d](/filings/0001026214-26-000021.md) | [5.8](/filings/0001026214-25-000060.md) | [6.0](/filings/0001026214-25-000086.md) | [5.8](/filings/0001026214-25-000116.md) | [6.3 d](/filings/0001026214-26-000021.md) | [5.9](/filings/0001026214-25-000060.md) | [5.9](/filings/0001026214-26-000046.md) | [5.7](/filings/0001026214-26-000063.md) | [5.8 d](/filings/0001026214-26-000021.md) | [6.0](/filings/0001026214-26-000046.md) | [6.8](/filings/0001026214-26-000063.md) |
| Interest expense | $bn | [22.1](/filings/0001026214-23-000104.md) | [23.1 d](/filings/0001026214-26-000021.md) | [23.6](/filings/0001026214-24-000039.md) | [24.1](/filings/0001026214-24-000068.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [0.7](/filings/0001026214-24-000097.md) | [0.7 d](/filings/0001026214-26-000021.md) | [0.7](/filings/0001026214-25-000060.md) | [0.7](/filings/0001026214-25-000086.md) | [0.7](/filings/0001026214-25-000116.md) | [0.8 d](/filings/0001026214-26-000021.md) | [0.7](/filings/0001026214-25-000060.md) | [0.6](/filings/0001026214-26-000046.md) | [0.7](/filings/0001026214-26-000063.md) | [0.7 d](/filings/0001026214-26-000021.md) | [0.9](/filings/0001026214-26-000046.md) | [0.8](/filings/0001026214-26-000063.md) |
| Net income | $bn | [2.7](/filings/0001026214-24-000097.md) | [2.9 d](/filings/0001026214-26-000021.md) | [2.8](/filings/0001026214-25-000060.md) | [2.8](/filings/0001026214-25-000086.md) | [3.1](/filings/0001026214-25-000116.md) | [3.2 d](/filings/0001026214-26-000021.md) | [2.8](/filings/0001026214-25-000060.md) | [2.4](/filings/0001026214-26-000046.md) | [2.8](/filings/0001026214-26-000063.md) | [2.8 d](/filings/0001026214-26-000021.md) | [3.8](/filings/0001026214-26-000046.md) | [3.2](/filings/0001026214-26-000063.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001026214-24-000097.md) | not reported | [0.01](/filings/0001026214-25-000060.md) | [0.00](/filings/0001026214-25-000086.md) | [(0.02)](/filings/0001026214-25-000116.md) | not reported | [(0.01)](/filings/0001026214-25-000060.md) | [(0.01)](/filings/0001026214-26-000046.md) | [0.00](/filings/0001026214-26-000063.md) | not reported | [0.00](/filings/0001026214-26-000046.md) | [0.01](/filings/0001026214-26-000063.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0001026214-24-000097.md) | not reported | [0.01](/filings/0001026214-25-000060.md) | [0.00](/filings/0001026214-25-000086.md) | [(0.02)](/filings/0001026214-25-000116.md) | not reported | [(0.01)](/filings/0001026214-25-000060.md) | [(0.01)](/filings/0001026214-26-000046.md) | [0.00](/filings/0001026214-26-000063.md) | not reported | [0.00](/filings/0001026214-26-000046.md) | [0.01](/filings/0001026214-26-000063.md) |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [3,272](/filings/0001026214-23-000104.md) | [3,281](/filings/0001026214-25-000040.md) | [3,287](/filings/0001026214-24-000039.md) | [3,307](/filings/0001026214-24-000068.md) | [3,343](/filings/0001026214-24-000097.md) | [3,387](/filings/0001026214-26-000021.md) | [3,409](/filings/0001026214-25-000060.md) | [3,436](/filings/0001026214-25-000086.md) | [3,468](/filings/0001026214-25-000116.md) | [3,498](/filings/0001026214-26-000063.md) | [3,518](/filings/0001026214-26-000046.md) | [3,532](/filings/0001026214-26-000063.md) |
| Total liabilities | $bn | [3,227](/filings/0001026214-23-000104.md) | [3,233](/filings/0001026214-25-000040.md) | [3,237](/filings/0001026214-24-000039.md) | [3,254](/filings/0001026214-24-000068.md) | [3,286](/filings/0001026214-24-000097.md) | [3,327](/filings/0001026214-26-000021.md) | [3,347](/filings/0001026214-25-000060.md) | [3,371](/filings/0001026214-25-000086.md) | [3,401](/filings/0001026214-25-000116.md) | [3,427](/filings/0001026214-26-000063.md) | [3,441](/filings/0001026214-26-000046.md) | [3,451](/filings/0001026214-26-000063.md) |
| Long-term debt | $bn | [3,196](/filings/0001026214-23-000104.md) | [3,202](/filings/0001026214-24-000025.md) | [3,203](/filings/0001026214-24-000039.md) | [3,219](/filings/0001026214-24-000068.md) | [3,251](/filings/0001026214-24-000097.md) | [167](/filings/0001026214-26-000021.md) | not reported | not reported | not reported | [169](/filings/0001026214-26-000063.md) | [164](/filings/0001026214-26-000046.md) | [157](/filings/0001026214-26-000063.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | [14.7](/filings/0001026214-26-000021.md) | not reported | not reported | not reported | [37.7](/filings/0001026214-26-000063.md) | [18.0](/filings/0001026214-26-000046.md) | [9.5](/filings/0001026214-26-000063.md) |
| Shareholders' equity | $bn | [44.7](/filings/0001026214-24-000097.md) | [47.7](/filings/0001026214-26-000021.md) | [50.5](/filings/0001026214-25-000060.md) | [53.2](/filings/0001026214-25-000086.md) | [56.4](/filings/0001026214-25-000116.md) | [59.6](/filings/0001026214-26-000021.md) | [62.4](/filings/0001026214-25-000060.md) | [64.8](/filings/0001026214-26-000046.md) | [67.6](/filings/0001026214-26-000063.md) | [70.4](/filings/0001026214-26-000063.md) | [77.8](/filings/0001026214-26-000046.md) | [81.0](/filings/0001026214-26-000063.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,571 d](/filings/0001026214-24-000068.md) | [726 d](/filings/0001026214-24-000097.md) | [1,883 d](/filings/0001026214-26-000021.md) | [2,894](/filings/0001026214-25-000060.md) | [927 d](/filings/0001026214-25-000086.md) | [3,706 d](/filings/0001026214-25-000116.md) | [(900) d](/filings/0001026214-26-000021.md) | [3,572](/filings/0001026214-25-000060.md) | [8,143 d](/filings/0001026214-26-000046.md) | [5,080 d](/filings/0001026214-26-000063.md) | [2,578 d](/filings/0001026214-26-000021.md) | [4,221 d](/filings/0001026214-26-000063.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [3,234](/filings/0001026214-23-000104.md) | [3,234](/filings/0001026214-24-000039.md) | [3,234](/filings/0001026214-24-000068.md) | [3,234](/filings/0001026214-24-000097.md) | [3,234](/filings/0001026214-25-000060.md) | [3,234](/filings/0001026214-25-000086.md) | [3,234](/filings/0001026214-25-000116.md) | [3,234](/filings/0001026214-25-000060.md) | [3,234](/filings/0001026214-26-000046.md) | [3,234](/filings/0001026214-26-000063.md) | [3,234](/filings/0001026214-26-000046.md) | [3,234](/filings/0001026214-26-000063.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 650,059,553 at 2026-10-06, from the cover of the [10-Q filed 2026-10-29](/filings/0001026214-26-000063.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 08:06 ET. No prices; not investment advice.